Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Berg

Showing results (231-240 of 547) with videos related to

Pageof 55
Sort By:
Journal of Alzheimer'S Disease : JAD|July 19, 2011
Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathwayWalter Maetzler, Anne Kathrin Stapf, Claudia Schulte, et al.
Journal of Alzheimer'S Disease : JAD|February 17, 2010
The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body diseaseWalter Maetzler, Benjamin Schmid, Matthis Synofzik, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 29, 2008
Autonomic dysfunction in different subtypes of multiple system atrophyClaudia Schmidt, Birgit Herting, Silke Prieur, et al.
Acta Neurochirurgica|June 24, 2010
Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patientsConstantin Roder, Vera Peters, Hidetoshi Kasuya, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|August 10, 2010
Common genetic polymorphisms in moyamoya and atherosclerotic disease in EuropeansConstantin Roder, Vera Peters, Hidetoshi Kasuya, et al.
Neuroepidemiology|September 21, 2013
Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase studyInga Liepelt-Scarfone, Katharina Gauss, Walter Maetzler, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 26, 2010
Analysis of ACTA2 in European Moyamoya disease patientsConstantin Roder, Vera Peters, Hidetoshi Kasuya, et al.
Frontiers in Neurology|August 24, 2019
Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?Franziska Hopfner, Markus A Hobert, Corina Maetzler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 29, 2007
Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brainJulia Fuchs, Ales Tichopad, Yulia Golub, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 7, 2017
Progression markers of motor deficits in Parkinson's disease: A biannual 4-year prospective studySebastian Heinzel, Felix P Bernhard, Benjamin Roeben, et al.
Pageof 55

Showing results (231-240 of 547) with videos related to

Sort By:
Pageof 55
Journal of Alzheimer'S Disease : JAD|July 19, 2011
Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathwayWalter Maetzler, Anne Kathrin Stapf, Claudia Schulte, et al.
Journal of Alzheimer'S Disease : JAD|February 17, 2010
The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body diseaseWalter Maetzler, Benjamin Schmid, Matthis Synofzik, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 29, 2008
Autonomic dysfunction in different subtypes of multiple system atrophyClaudia Schmidt, Birgit Herting, Silke Prieur, et al.
Acta Neurochirurgica|June 24, 2010
Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patientsConstantin Roder, Vera Peters, Hidetoshi Kasuya, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|August 10, 2010
Common genetic polymorphisms in moyamoya and atherosclerotic disease in EuropeansConstantin Roder, Vera Peters, Hidetoshi Kasuya, et al.
Neuroepidemiology|September 21, 2013
Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase studyInga Liepelt-Scarfone, Katharina Gauss, Walter Maetzler, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 26, 2010
Analysis of ACTA2 in European Moyamoya disease patientsConstantin Roder, Vera Peters, Hidetoshi Kasuya, et al.
Frontiers in Neurology|August 24, 2019
Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?Franziska Hopfner, Markus A Hobert, Corina Maetzler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 29, 2007
Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brainJulia Fuchs, Ales Tichopad, Yulia Golub, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 7, 2017
Progression markers of motor deficits in Parkinson's disease: A biannual 4-year prospective studySebastian Heinzel, Felix P Bernhard, Benjamin Roeben, et al.
Pageof 55